References
- Rosenberg B., Van Camp L., Krigas T. Nature 1965; 205: 698–699
- Rosenberg B., Van Camp L., Trosko J. E., Mansour V. H. Nature 1969; 222: 385–386
- Khan M. W.A., Sadler P. J. Chem. Biol. Interact. 1978; 21: 227–232
- Pascoe J. M., Roberts J. J. Blochem. Pharmacol. 1974; 23: 1345–1357
- Van Denberg H. W., Roberts J. J. Chem. Biol. Interact. 1976; 12: 375–390
- Taylor D. M. Biochlmie 1978; 60: 949–956
- Lange R. C., Spencer R. P., Harder H. C. J. Nucl. Med. 1973; 14: 191–195
- Wolf W., Manaka R. E. J. Clin. Haemat. Oncol. 1977; 7: 79–95
- Lange R. E., Spencer R. P., Harder H. C. J. Nucl. Med. 1972; 13: 328–330
- De Conti R. E., Toflness B. R., Lange R. E., Creasey W. A. Cancer Res. 1973; 33: 1310–1315
- Smith P. H.S., Taylor D. M. J. Nucl. Med. 1974; 15: 349–351
- Wolf W., Manaka R. C., Ingalls R. B. Radiopharmaceuticals and Labelled Compounds. Internat. Atomic Energy Agency, Vienna 1973; 205–221
- Bannister S. J., Sternson L. A., Repta A. J., James G. W. Clin. Chem. 1977; 23: 2258–2262
- Le Roy A. F., Lutz R. J., Dedrick R. L., Li Uerest C. L., Guarino A. M. Cancer Treat. Rep. 1979; 63: 59–71
- Smith P. H., Taylor D. M. J. Nucl. Med. 1974; 15: 349–351
- Kirby K. S. Blochem. J. 1957; 66: 495–504
- Kirby K. S., Cook E. A. Blochem. J. 1967; 104: 254–257
- Ridgwary H., Speer R. J., Hall L. M., Stewart D. P., Newman A. D., Gennings A., Zapata A., Broom V., Hiu J. M. J. Clin. Haemat. Oncol. 1978; 8: 1–10
- Wolf W., Berman J., Leh F., Poggenburg K. Adv. Nucl. Med. Proc. World Congr. Nucl. Med., Tokyo 1975; 944
- Taylor D. M., Tew K. D., Jones J. D. Europ. J. Cancer 1976; 12: 249–254
- Jankowski K., Sbler F., Turkkan N. Blomed. Mass Spec. 1981; 9: 91–93
- Jankowski K., Soler F. Burop. J. Mass Spec. 1980; 1: 45–52